HDAC inhibitors and therapeutic use thereof
US12043607B2 · kind B2 · utility
0Cited by
0References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2022 |
| Grant date | Jul 23, 2024 |
| Priority date | — |
| Expiry date | Dec 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are novel compounds, compositions and methods for treatment of diseases including cancer using such compounds, compositions, and methods. The compounds include those of Formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.